Literature DB >> 28686153

Heparin-like effect resistant to protamine in a child with haemorrhagic shock. Do we need heparinase?

Mirco Nacoti1, Diego Cantù2, Daniele Bonacina1, Federico Lussana3, Ezio Bonanomi1, Marina Marchetti4, Anna Falanga4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28686153      PMCID： PMC6034779          DOI： 10.2450/2017.0088-17

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  14 in total

1.  Use of heparinase I in a patient with protamine allergy undergoing redo myocardial revascularization.

Authors:  F E Ralley; B De Varennes
Journal:  J Cardiothorac Vasc Anesth       Date:  2000-12       Impact factor: 2.628

2.  A dose-determining trial of heparinase-I (Neutralase) for heparin neutralization in coronary artery surgery.

Authors:  E K Heres; J C Horrow; G P Gravlee; B E Tardiff; J Luber; J Schneider; T Barragry; R Broughton
Journal:  Anesth Analg       Date:  2001-12       Impact factor: 5.108

3.  Extraction of a heparin-like substance from mast cell granules in mouse connective tissue.

Authors:  M KOKSAL
Journal:  Nature       Date:  1953-10-17       Impact factor: 49.962

4.  Effects of unfractionated heparin, low-molecular-weight heparin, and heparinoid on thromboelastographic assay of blood coagulation.

Authors:  K Zmuda; D Neofotistos; C H Ts'ao
Journal:  Am J Clin Pathol       Date:  2000-05       Impact factor: 2.493

5.  Evaluation of coagulation during cardiopulmonary bypass with a heparinase-modified thromboelastographic assay.

Authors:  K J Tuman; R J McCarthy; M Djuric; V Rizzo; A D Ivankovich
Journal:  J Cardiothorac Vasc Anesth       Date:  1994-04       Impact factor: 2.628

6.  Hepatoenteric ischemia-reperfusion increases circulating heparinoid activity in rabbits.

Authors:  V G Nielsen; B T Geary
Journal:  J Crit Care       Date:  2000-12       Impact factor: 3.425

7.  Endogenous heparin-like activity detected by anti-Xa assay in infected cirrhotic and non-cirrhotic patients.

Authors:  A Zambruni; U Thalheimer; J Coppell; A Riddell; A Mancuso; G Leandro; D Perry; A K Burroughs
Journal:  Scand J Gastroenterol       Date:  2004-09       Impact factor: 2.423

8.  Heparin elimination in patients with liver cirrhosis.

Authors:  A N Teien
Journal:  Thromb Haemost       Date:  1977-10-31       Impact factor: 5.249

9.  Removal of the anticoagulant activities of the low molecular weight heparin fractions and fragments with flavobacterial heparinase.

Authors:  V C Yang; H Bernstein; C L Cooney; J C Kadam; R Langer
Journal:  Thromb Res       Date:  1986-12-01       Impact factor: 3.944

10.  Heparin-like effect contributes to the coagulopathy in patients with acute liver failure undergoing liver transplantation.

Authors:  Marco Senzolo; Seema Agarwal; Paola Zappoli; Sushang Vibhakorn; Susan Mallett; Andrew K Burroughs
Journal:  Liver Int       Date:  2009-02-09       Impact factor: 5.828
View more
  2 in total

1.  Acquired haemophilia A: Italian Consensus Recommendations on diagnosis, general management and treatment of bleeding.

Authors:  Antonio Coppola; Massimo Franchini; Armando Tripodi; Rita C Santoro; Giancarlo Castaman; Renato Marino; Ezio Zanon; Cristina Santoro; Gianna F Rivolta; Laura Contino; Raimondo De Cristofaro; Angelo C Molinari; Paolo Gresele; Angiola Rocino
Journal:  Blood Transfus       Date:  2022-01-20       Impact factor: 5.752

2.  Structural characterization of a clinically described heparin-like substance in plasma causing bleeding.

Authors:  Yanlei Yu; Karen Bruzdoski; Vadim Kostousov; Lisa Hensch; Shiu-Ki Hui; Fakiha Siddiqui; Amber Farooqui; Ahmed Kouta; Fuming Zhang; Jawed Fareed; Jun Teruya; Robert J Linhardt
Journal:  Carbohydr Polym       Date:  2020-05-19       Impact factor: 9.381
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.